Discover the next level of cancer care with our liquid biopsy products. Our comprehensive product line, including DxLiquid Pan100 and DxLiquid TMB500,
targets somatic mutations through ctDNA analysis. We offer valuable support in treatment selection, response monitoring, and recurrence detection,
ensuring optimal management for cancer patients.
DxLiquid (All-In-One)
Probe Mix (Pan100)
Probe Mix (TMB500)
Magnetic Circulating DNA Maxi Reagent
Workflow
Dxome Solution
-
Sample
Collection -
-
Sample
Preparation -
-
Target
Enrichment -
-
Sequencing
-
-
Analysis &
Report
Bioinformatics Software
-
High Precision
Utilizing state-of-the-art algorithms, our software accurately analyzes tumor DNA from blood samples, ensuring precise detection of genetic mutations.
-
UMI-Free
Our proprietary core algorithms enable comparable or superior performance without requiring Unique Molecular Identifiers (UMIs).
-
Continuous Updates
Benefit from regular software updates that incorporate the latest advancements in genomic research, ensuring access to the most up-to-date analysis tools and features.
-
Comprehensive Annotation
Users are able to view all the information at a single glance allowing examination of crucial information according to ASCO, AMP & CAP guidelines.
DxLiquid Products
Discover the unparalleled advantages of DxLiquid, an innovative blood-based test for diagnosing and monitoring various cancers.
Portfolio
-
ProductGenes
-
Product
Breast
Genes
49
-
Product
Colon
Genes
41
-
Product
Esophagus
Genes
27
-
Product
Kidney
Genes
16
-
Product
Lung
Genes
47
-
Product
Lymphoma
Genes
116
-
Product
MRD30
Genes
30
-
Product
Ovarian
Genes
9
-
Product
Pan100
Genes
105
-
Product
Pancreatobiliary
Genes
41
*Gene numbers may be updated
Need Technical Support or Ready to Order?
Our team is here to help! Whether you have questions about our NGS kits or need assistance with placing an order, feel free to reach out for expert support.
Request-
01
Non-Invasive Testing
Conducted using a simple blood sample, DxLiquid is less invasive compared to traditional tissue biopsies, minimizing discomfort for patients.
-
02
Real-Time Monitoring of Recurrence and Metastasis
Monitor genetic changes in tumors in real-time, allowing for the evaluation of treatment effectiveness and early detection of recurrence.
-
03
Early Diagnosis
Detect the presence of early-stage cancers, enabling prompt treatment initiation and improving patient outcomes.
-
04
Comprehensive Cancer Analysis
DxLiquid offers a thorough analysis of multiple cancer types, detecting a wide range of tumor markers in a single test.
-
05
Predictive Treatment Response
Analysis of the genetic characteristics of the tumor allows prediction of how patients will respond to specific treatments, facilitating personalized treatment plans.
-
06
Rapid Results
Receive quick test results, enabling fast diagnosis and timely treatment planning.
